首页> 外文期刊>Nuclearmedicine >Percutaneous microwave ablatin of benign thyroid nodules Functional imaging in comparison to nodular volume reduction at a 3-month follow-up
【24h】

Percutaneous microwave ablatin of benign thyroid nodules Functional imaging in comparison to nodular volume reduction at a 3-month follow-up

机译:经皮微波消融甲状腺良性结节功能成像与3个月随访结节体积缩小的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: Thyroid nodules represent a common clinical issue. Amongst other minimally invasive procedures, percutaneous microwave ablation (MWA) poses a promising new approach. The goal of this retrospective study is to find out if there is a correlation between volume reduction after 3 months and Tc-99m-uptake reduction of treated thyroid nodules. Patients, methods: 14 patients with 18 nodules were treated with MWA. Pre-ablative assessment included sonographical and functional imaging of the thyroid with Tc-99m-pertechnetate and Tc-99m-MIBI. Additionally, patients underwent thyroid scintigraphy 24 hours after ablation in order to evaluate the impact of the treatment on a functional level and to ensure sufficient ablation of the targeted area. At a 3-month follow-up, ultrasound examination was performed to assess nodular volume reduction. Results: Mean relative nodular volume reduction after three months was 55.4 +/- 17.9% (p < 0.05). Tc-99m-uptake 24 hours after treatment was 45.2 +/- 31.9% (Tc-99m-MIBI) and 35.7 +/- 20.3% (Tc-99m-pertechnetate) lower than prior to ablation (p < 0.05). Correlating reduction of volume and Tc-99m-uptake, Pearson's r was 0.41 (p < 0.05) for nodules imaged with Tc-99m-MIBI and -0.98 (p < 0.05) for Tc-99m-pertechnetate. According to scintigraphy 99.6 +/- 22.6% of the determined target area could be successfully ablated. Conclusions: MWA can be considered as an efficient, low-risk and convenient new approach to the treatment of benign thyroid nodules. Furthermore, scintigraphy seems to serve as a potential prognostic tool for the later morphological outcome, allowing rapid evaluation of the targeted area in post-ablative examination.
机译:目的:甲状腺结节代表常见的临床问题。在其他微创手术中,经皮微波消融(MWA)提出了一种有希望的新方法。这项回顾性研究的目的是发现3个月后的甲状腺结节体积减少与Tc-99m摄取减少之间是否存在相关性。患者,方法:14例18个结节的患者接受了MWA治疗。消融前评估包括使用Tc-99m-高tech酸酯和Tc-99m-MIBI对甲状腺进行超声检查和功能成像。此外,消融后24小时对患者进行甲状腺闪烁显像,以评估治疗对功能水平的影响并确保对目标区域进行充分消融。在3个月的随访中,进行了超声检查以评估结节体积的减少。结果:三个月后平均相对结节体积减少为55.4 +/- 17.9%(p <0.05)。治疗后24小时的Tc-99m摄取比消融前低45.2 +/- 31.9%(Tc-99m-MIBI)和35.7 +/- 20.3%(Tc-99m-高per酸酯)(p <0.05)。与体积减少和Tc-99m摄取相关,Pearson的r对于用Tc-99m-MIBI成像的结节为0.41(p <0.05),对于Tc-99m-高per酸盐为-0.98(p <0.05)。根据闪烁显像术可以成功消融99.6 +/- 22.6%的目标区域。结论:MWA被认为是治疗甲状腺良性结节的一种有效,低风险,方便的新方法。此外,闪烁显像似乎可以作为以后形态学结果的潜在预后工具,从而可以在消融后检查中快速评估目标区域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号